NT-proBNP has been well-established in the clinical diagnosis of HF [4], whereas Gal-3—although not clinically used—has been presented in recent literature as a promising biomarker candidate for the diagnosis of HFpEF [7,26]. This evidence concerns the gene NPPB and hydrops fetalis.